Rosenberg, ScD, led a survey that found women who have double mastectomies
generally overestimate their likelihood of getting cancer in the healthy
Dr. Judy Garber comments on Dana-Farber researchers using healthy breast tissue from high-risk patients to prevent breast cancer.
Rachel Freedman commented on targeted treatments – those that attack a specific
characteristic of a cancer strain – becoming the norm in breast cancer care.
Dr. Eric Winer served as chair for a panel that developed the second international guidelines for management of advanced breast cancer.
Tags: BreastCancer, Radiation
The Dana-Farber Mammography Van and the Blum Family Van travel around the Greater Boston area providing cancer screenings.
Tags: BreastCancer, PatientSupport, YawkeyCenter, Prevention, Imaging
In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.
E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine
significantly prolonged progression-free survival in patients with progressive
HER2-positive advanced breast cancer.
Eric P. Winer co-chaired an expert panel that developed a clinical practice
guideline on disease management for patients with advanced HER2-positive breast
cancer and brain metastases.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: